HSC01
clear graphic
clear graphic

Registration open for funshoot benefiting CTRC

Posted on Tuesday, August 20, 2013 · Volume: XLVI · Issue: 17


The Vulcan Funshoot Sept. 7 gives sporting-clay enthusiasts a fun way to help raise funds for the Cancer Therapy & Research Center at the UT Health Science Center San Antonio. Call Vulcan Materials Company at 210-524-3515 to register or for sponsorship information. Click on photo for larger view
clear graphic
The Vulcan Funshoot Sept. 7 gives sporting-clay enthusiasts a fun way to help raise funds for the Cancer Therapy & Research Center at the UT Health Science Center San Antonio. Call Vulcan Materials Company at 210-524-3515 to register or for sponsorship information. Click on photo for larger viewclear graphic

Email Printer Friendly Format
 

By Catherine Duncan

SAN ANTONIO (Aug. 2, 2013) ó Registration is underway for the 20th annual Vulcan Materials Funshoot, a sporting-clay competition benefiting the Cancer Therapy & Research Center (CTRC) at the UT Health Science Center San Antonio. This yearís fundraiser is scheduled for Saturday, Sept. 7.

Individuals can sign up to shoot for $350 per person. Sponsorships are available at three levels with all sponsorships including a team of five shooters. Sponsor levels are platinum, at $5,000; diamond, at $2,500; and gold, at $1,500. Businesses and individuals also can donate items for the silent and live auctions.

The competition is held at the National Shooting Complex, 5931 Roft Road, off Culebra Road and outside Loop 1604. In the past 19 years, Vulcan Materials Southwest Division has raised more than $1.83 million to support the CTRCís mission to conquer cancer through research, prevention and treatment.

To register and for sponsorship information, call Vulcan Materials Company at 210-524-3515.

# # #

The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI)-designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.

 
Share |

Top stories this week »



bottom bar

printer friendly format »
view more articles by issue »
search articles by keywords »
Arrow - to top
Arrow - to top